Radioimmunotherapy with 90Y-ibritumomab. Twelve years experience - Lara Martinez, M; Medina Romero, F; Cabrera Veloz, I; Canelas Subieta, M; Lakhwani Lakhwani, S; Fernandez Belmonte, F; Gonzalez Diaz, M; Gomez Rodriguez, M (European Journal Of Nuclear Medicine And Molecular Imaging, 2019)